Al Awaidy, S. and Althaqafi, A. and Dbaibo, G. and Abuglia, M. and Abusrewil, S. and Aksakal, F.N.B. and Barakat, A. and Dahbi, Z. and Derrar, M.F. and El-Hefnawy, M.H. and Esteghamati, A. and Ghasemi, M. and Hadeed, I. and Hassan, M.B. and Idris, O. and Kara, A. and Mardani, M. and Nourlil, J. and Tarraf, H. and Slim, A. and �nal, S. and Hasan, M.Y.A. and East/North, Middle (2018) A snapshot of influenza surveillance, vaccine recommendations, and vaccine access, drivers, and barriers in selected Middle Eastern and North African countries. Oman Medical Journal, 33 (4). pp. 283-290.
|
Text
A snapshot of influenza surveillance, vaccine recommendations, and vaccine access, drivers, and barriers in selected Middle Eastern and North African countries.pdf Download (432kB) | Preview |
Abstract
Objectives: Influenza is a vaccine-preventable acute respiratory viral infection that causes epidemics annually around the globe. A regional influenza stakeholder network (MENA-ISN) comprised of experts assessed the status of influenza prevention and control using a structured survey. Methods: A survey questionnaire was used to obtain information from each participating country on surveillance system, the burden of disease, influenza vaccination programs, recommendations, funding and access for vaccine and vaccination, target rate, coverage rate monitoring, and drivers and barriers to influenza vaccination. Results: Out of the 10 countries that participated, nine had an influenza surveillance system and vaccination policy, and seven had World Health Organization (WHO) accredited reference laboratory. Three countries had burden of disease data available and eight had a reimbursement vaccine policy. Influenza vaccine was available in five countries through the Ministry of Health whereas in others, pharmacies also dispensed for the private sector. In all countries, prescribers were physicians, and vaccinators, which could be physicians, nurses, and pharmacists. Eight countries had a set vaccination target rate and only three monitored the influenza coverage rates. Drivers and barriers of vaccination were similar in all countries. Conclusions: Despite existing policies, influenza vaccination coverage remains far below the WHO recommendations. Increased awareness and effective implementation of policies with collaboration of stakeholders can help increase the rates to reach WHO targets. © 2018, Oman Medical Specialty Board. All rights reserved.
Item Type: | Article |
---|---|
Additional Information: | cited By 0 |
Uncontrolled Keywords: | influenza vaccine, Article; chronic disease; disease burden; disease surveillance; general practice; health care personnel; high risk population; human; influenza; influenza vaccination; physician; practice guideline; pregnant woman; prevention and control; public health service; questionnaire; world health organization |
Subjects: | QW Microbiology. Immunology |
Depositing User: | eprints admin |
Date Deposited: | 29 Sep 2018 11:33 |
Last Modified: | 08 Sep 2019 04:40 |
URI: | http://eprints.iums.ac.ir/id/eprint/6385 |
Actions (login required)
![]() |
View Item |